Rueda, Ariana
Mendoza, Julian I.
Alba-Castellon, Lorena
Parladé, Eloi
Voltà-Durán, Eric
Paez, David
Aviño, Anna
Eritja, Ramon
Vázquez, Esther
Villaverde, Antonio
Mangues, Ramón
Unzueta, Ugutz
Article History
Received: 5 May 2023
Accepted: 7 August 2023
First Online: 22 September 2023
Ethics
: <b>Conflict of interest</b> The authors declare that they have no conflict of interest. Mangues R, Vazquez E and Villaverde A are co-founders of Nanoligent SL, a company devoted to developing nanostructured drugs for cancer treatment. Mangues R, Vázquez E, Villaverde A, Parladé E and Unzueta U are inventors of a patent covering the use of HSNBT for biomedical applications.